MOVED: a web-based mood-elevating program for Veterans with PTSD

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial evaluates MOVED, a self-guided web-based intervention designed to elicit moral elevation in Veterans with PTSD. The study compares MOVED to a generic supportive control over 4 weeks (8 sessions) to see if it reduces PTSD symptoms and improves social functioning and quality of life. Participants must have PTSD, be English-speaking, and have internet access, with enrollment limited to those in the VISN 17 system and without certain comorbid conditions or ongoing trauma-focused therapies. The primary care setting is a VA health system site in Temple, Texas, targeting feasible, scalable, stand-alone treatment options. Outcomes include PTSD symptom change and broader psychosocial functioning.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Enrolled in a VISN 17 health care system
* English-speaking and able to provide written informed consent
* Willingness to complete study procedures and be randomized
* Internet access and an electronic device to complete the web-based sessions
* Current diagnosis of PTSD based on the CAPS-5
* History of PTSD diagnosis for at least 1 year

Exclusion Criteria:

* History of severe traumatic brain injury indicated by medical record review and the Ohio State Traumatic Brain Injury Identification Method (OSU TBI-ID)
* Current psychosis or mania as indicated by medical record review and the Mini International Neuropsychiatric Interview (MINI)
* Current suicide risk based on the Beck Depression Inventory-II (BDI-II)
* Currently enrolled and actively participating in a trauma-focused treatment including:

  * Cognitive Processing Therapy
  * Prolonged Exposure
  * Eye Movement Desensitization Reprocessing

Where it's running

• Central Texas Veterans Health Care System, Temple, TX
  Temple, Texas, United States Recruiting

Study contacts

• Principal investigator: Adam P. McGuire, PhD — Central Texas Veterans Health Care System, Temple, TX
• Study coordinator: Adam P McGuire, PhD
• Email: Adam.McGuire@va.gov
• Phone: (254) 297-5173

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Reboxetine plus Ritalin vs Dog-Assisted Therapy for PTSD

  This study tests whether a drug combo of reboxetine and methylphenidate works better than dog-assisted therapy for people with PTSD.

  Recruiting Phase 2 University of Haifa · Haifa · NCT07771530

• Self-Help CPT with WoVeN Peer Support for Women Veterans with PTSD

  This study tests a self-help Cognitive Processing Therapy and a WoVeN peer-support program, alone and together, to see if they improve PTSD symptoms and well-being for women veterans.

  Recruiting Boston University · Boston, Massachusetts · NCT07250061

• Adaptive, personalized PTSD care for veterans

  This program will try different therapy sequences plus optional text-message homework reminders to see if switching treatments or sending prompts helps veterans with PTSD who aren't improving or are missing between-session homework.

  Recruiting at 3 sites The University of Texas Health Science Center at San Antonio · Augusta, Georgia and 3 other locations · NCT07176273

• Multi‑Mode Cognitive Processing Therapy for adults with PTSD

  This program will try a multi‑mode form of Cognitive Processing Therapy to reduce PTSD symptoms and improve sleep and mood in adults aged 20–65 with PTSD.

  Recruiting Far Eastern Memorial Hospital · New Taipei City, Banqiao District · NCT07105345

• Improving thinking, daily functioning, mood, and sleep after mild traumatic brain injury and PTSD

  This project will test whether adding morning bright light therapy to compensatory cognitive training helps post-9/11 Veterans with mild traumatic brain injury and PTSD think, function, and sleep better compared with a neutral ion generator.

  Recruiting at 2 sites VA Office of Research and Development · San Diego, California and 1 other locations · NCT07055633

• Combined MDMA and psilocybin treatment for Veterans with PTSD

  This trial tests whether giving MDMA followed 30 minutes later by psilocybin can be safely used to reduce symptoms in military veterans with long-standing PTSD.

  Recruiting Phase 1 Johns Hopkins University · Baltimore, Maryland · NCT06989957

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.